Cul1  ||| S:0 E:5 ||| NNP
promotes  ||| S:5 E:14 ||| VBZ
melanoma  ||| S:14 E:23 ||| JJ
cell  ||| S:23 E:28 ||| NN
proliferation  ||| S:28 E:42 ||| NN
by  ||| S:42 E:45 ||| IN
promoting  ||| S:45 E:55 ||| VBG
DEPTOR  ||| S:55 E:62 ||| NNP
degradation  ||| S:62 E:74 ||| NN
and  ||| S:74 E:78 ||| CC
enhancing  ||| S:78 E:88 ||| VBG
cap-dependent  ||| S:88 E:102 ||| JJ
translation  ||| S:102 E:114 ||| NN
Cullin1  ||| S:114 E:122 ||| NNP
( ||| S:122 E:123 ||| -LRB-
Cul1 ||| S:123 E:127 ||| NNP
)  ||| S:127 E:129 ||| -RRB-
serves  ||| S:129 E:136 ||| VBZ
as  ||| S:136 E:139 ||| IN
a  ||| S:139 E:141 ||| DT
rigid  ||| S:141 E:147 ||| JJ
scaffold  ||| S:147 E:156 ||| NN
in  ||| S:156 E:159 ||| IN
the  ||| S:159 E:163 ||| DT
SCF  ||| S:163 E:167 ||| NNP
( ||| S:167 E:168 ||| -LRB-
Skp1 ||| S:168 E:172 ||| FW
/ ||| S:172 E:173 ||| FW
Cullin ||| S:173 E:179 ||| FW
/ ||| S:179 E:180 ||| FW
Rbx1 ||| S:180 E:184 ||| FW
/ ||| S:184 E:185 ||| FW
F-box  ||| S:185 E:191 ||| FW
protein ||| S:191 E:198 ||| FW
)  ||| S:198 E:200 ||| -RRB-
E3 ubiquitin  ||| S:200 E:213 ||| CD
ligase  ||| S:213 E:220 ||| JJ
complex  ||| S:220 E:228 ||| NN
and  ||| S:228 E:232 ||| CC
has  ||| S:232 E:236 ||| VBZ
been  ||| S:236 E:241 ||| VBN
found  ||| S:241 E:247 ||| VBN
to  ||| S:247 E:250 ||| TO
be  ||| S:250 E:253 ||| VB
overexpressed  ||| S:253 E:267 ||| VBN
in  ||| S:267 E:270 ||| IN
melanoma  ||| S:270 E:279 ||| NN
and  ||| S:279 E:283 ||| CC
to  ||| S:283 E:286 ||| TO
enhance  ||| S:286 E:294 ||| VB
melanoma  ||| S:294 E:303 ||| JJ
cell  ||| S:303 E:308 ||| NN
proliferation  ||| S:308 E:322 ||| NN
by  ||| S:322 E:325 ||| IN
promoting  ||| S:325 E:335 ||| VBG
G1-S phase  ||| S:335 E:346 ||| CD
transition ||| S:346 E:356 ||| NN
.  ||| S:356 E:358 ||| .
However ||| S:358 E:365 ||| RB
,  ||| S:365 E:367 ||| ,
the  ||| S:367 E:371 ||| DT
underlying  ||| S:371 E:382 ||| JJ
mechanisms  ||| S:382 E:393 ||| NNS
involved  ||| S:393 E:402 ||| VBN
in  ||| S:402 E:405 ||| IN
the  ||| S:405 E:409 ||| DT
regulation  ||| S:409 E:420 ||| NN
of  ||| S:420 E:423 ||| IN
melanoma  ||| S:423 E:432 ||| JJ
cell  ||| S:432 E:437 ||| NN
proliferation  ||| S:437 E:451 ||| NN
by  ||| S:451 E:454 ||| IN
Cul1  ||| S:454 E:459 ||| NNP
remain  ||| S:459 E:466 ||| VBP
poorly  ||| S:466 E:473 ||| RB
understood ||| S:473 E:483 ||| VBN
.  ||| S:483 E:485 ||| .
In  ||| S:485 E:488 ||| IN
the  ||| S:488 E:492 ||| DT
present  ||| S:492 E:500 ||| JJ
study ||| S:500 E:505 ||| NN
,  ||| S:505 E:507 ||| ,
we  ||| S:507 E:510 ||| PRP
found  ||| S:510 E:516 ||| VBD
that  ||| S:516 E:521 ||| IN
Cul1  ||| S:521 E:526 ||| CD
promoted  ||| S:526 E:535 ||| CD
mTORC1  ||| S:535 E:542 ||| CD
activity  ||| S:542 E:551 ||| NN
and  ||| S:551 E:555 ||| CC
cap-dependent  ||| S:555 E:569 ||| JJ
translation  ||| S:569 E:581 ||| NN
by  ||| S:581 E:584 ||| IN
enhancing  ||| S:584 E:594 ||| VBG
the  ||| S:594 E:598 ||| DT
ubiquitination  ||| S:598 E:613 ||| NN
and  ||| S:613 E:617 ||| CC
degradation  ||| S:617 E:629 ||| NN
of  ||| S:629 E:632 ||| IN
DEPTOR ||| S:632 E:638 ||| NNP
.  ||| S:638 E:640 ||| .
We  ||| S:640 E:643 ||| PRP
further  ||| S:643 E:651 ||| RB
showed  ||| S:651 E:658 ||| VBD
that  ||| S:658 E:663 ||| DT
suppression  ||| S:663 E:675 ||| NN
of  ||| S:675 E:678 ||| IN
the  ||| S:678 E:682 ||| DT
eIF4F  ||| S:682 E:688 ||| JJ
complex  ||| S:688 E:696 ||| JJ
assembly  ||| S:696 E:705 ||| NN
profoundly  ||| S:705 E:716 ||| RB
inhibited  ||| S:716 E:726 ||| VBD
the  ||| S:726 E:730 ||| DT
promoting  ||| S:730 E:740 ||| VBG
effect  ||| S:740 E:747 ||| NN
of  ||| S:747 E:750 ||| IN
Cul1  ||| S:750 E:755 ||| CD
on  ||| S:755 E:758 ||| IN
melanoma  ||| S:758 E:767 ||| JJ
cell  ||| S:767 E:772 ||| NN
proliferation ||| S:772 E:785 ||| NN
,  ||| S:785 E:787 ||| ,
while  ||| S:787 E:793 ||| IN
enhancement  ||| S:793 E:805 ||| NN
of  ||| S:805 E:808 ||| IN
the  ||| S:808 E:812 ||| DT
eIF4F  ||| S:812 E:818 ||| JJ
complex  ||| S:818 E:826 ||| JJ
activity  ||| S:826 E:835 ||| NN
reversed  ||| S:835 E:844 ||| VBD
the  ||| S:844 E:848 ||| DT
inhibitory  ||| S:848 E:859 ||| JJ
effect  ||| S:859 E:866 ||| NN
of  ||| S:866 E:869 ||| IN
Cul1  ||| S:869 E:874 ||| CD
depletion  ||| S:874 E:884 ||| NN
on  ||| S:884 E:887 ||| IN
melanoma  ||| S:887 E:896 ||| JJ
cell  ||| S:896 E:901 ||| NN
proliferation ||| S:901 E:914 ||| NN
,  ||| S:914 E:916 ||| ,
indicating  ||| S:916 E:927 ||| VBG
that  ||| S:927 E:932 ||| IN
Cul1  ||| S:932 E:937 ||| NNP
contributes  ||| S:937 E:949 ||| VBZ
to  ||| S:949 E:952 ||| TO
melanoma  ||| S:952 E:961 ||| VB
cell  ||| S:961 E:966 ||| NN
proliferation  ||| S:966 E:980 ||| NN
by  ||| S:980 E:983 ||| IN
activating  ||| S:983 E:994 ||| CD
cap‑dependent  ||| S:994 E:1008 ||| CD
translation ||| S:1008 E:1019 ||| NN
.  ||| S:1019 E:1021 ||| .
These  ||| S:1021 E:1027 ||| DT
data  ||| S:1027 E:1032 ||| NNS
elucidate  ||| S:1032 E:1042 ||| VBP
the  ||| S:1042 E:1046 ||| DT
role  ||| S:1046 E:1051 ||| NN
of  ||| S:1051 E:1054 ||| IN
Cul1  ||| S:1054 E:1059 ||| CD
in  ||| S:1059 E:1062 ||| IN
cap-dependent  ||| S:1062 E:1076 ||| JJ
translation  ||| S:1076 E:1088 ||| NN
and  ||| S:1088 E:1092 ||| CC
improves  ||| S:1092 E:1101 ||| VBZ
our  ||| S:1101 E:1105 ||| PRP$
understanding  ||| S:1105 E:1119 ||| NN
of  ||| S:1119 E:1122 ||| IN
the  ||| S:1122 E:1126 ||| DT
underlying  ||| S:1126 E:1137 ||| JJ
mechanisms  ||| S:1137 E:1148 ||| NNS
involved  ||| S:1148 E:1157 ||| VBN
in  ||| S:1157 E:1160 ||| IN
the  ||| S:1160 E:1164 ||| DT
regulation  ||| S:1164 E:1175 ||| NN
of  ||| S:1175 E:1178 ||| IN
melanoma  ||| S:1178 E:1187 ||| JJ
cell  ||| S:1187 E:1192 ||| NN
proliferation  ||| S:1192 E:1206 ||| NN
by  ||| S:1206 E:1209 ||| IN
Cul1 ||| S:1209 E:1213 ||| CD
.  ||| S:1213 E:1215 ||| .
